Laser photocoagulation therapy
Orphan DrugFDA Approved
Description
Fetoscopic laser photocoagulation is the gold standard treatment for twin-to-twin transfusion syndrome (TTTS). The procedure involves using laser energy to ablate placental vascular anastomoses that cause unbalanced blood flow between twins. This minimally invasive fetal surgery significantly improves survival and neurological outcomes.
Indications & Therapeutic Use
Twin-to-twin transfusion syndrome, severe TTTS stages II-IV
Linked Diseases:
Global Availability (8 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Laser photocoagulation therapy
| Generic Name | Laser photocoagulation therapy |
| Active Ingredient | N/A - Procedural intervention |
| Drug Class | Twin-to-twin transfusion syndrome |
| Manufacturer | Various medical device manufacturers |
| Dosage Forms | Fetoscopic surgical procedure |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Not Required |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00093847 |
| Countries | 8 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations9 Validated Nodes